| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics, Inc. | FINANCIAL OFFICER, (PFO & PAO) | Stock Options (right to buy) | 50K | $76K | $1.52 | Feb 10, 2023 | Direct |
| Bellerophon Therapeutics, Inc. | FINANCIAL OFFICER, (PFO & PAO) | Common Stock | 12.5K | $1.29K | $0.10 | Dec 9, 2022 | Direct |
| Bellerophon Therapeutics, Inc. | FINANCIAL OFFICER, (PFO & PAO) | Restricted Stock Units | 18K | Dec 9, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BLPH | Bellerophon Therapeutics, Inc. | Feb 10, 2023 | 1 | $76K | 4 | Feb 14, 2023 | FINANCIAL OFFICER, (PFO & PAO) |
| BLPH | Bellerophon Therapeutics, Inc. | Dec 9, 2022 | 3 | -$5.14K | 4 | Dec 13, 2022 | FINANCIAL OFFICER, (PFO & PAO) |
| BLPH | Bellerophon Therapeutics, Inc. | Jan 26, 2022 | 1 | $0 | 4 | Jan 28, 2022 | FINANCIAL OFFICER, (PFO & PAO) |
| BLPH | Bellerophon Therapeutics, Inc. | Sep 30, 2021 | 0 | $0 | 3 | Oct 8, 2021 | Controller, (PFO & PAO) |